Hyperglycemia from Real-World Dawn Phenomenon Is Nearly Eliminated with the MiniMed 780G System (MM780G)

被引：0
|
作者：
McVean, Jennifer
Shin, John
Niu, Fang
Diaz-Garelli, Franck
Vigersky, Robert A.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-972-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
972-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effect of Optimized Settings during Six Months of Real-World MiniMed 780G Advanced Hybrid Closed-Loop (AHCL) Therapy Use in Chile
    Castro, Matias
    Bonilla, Camila Nicole Carrasco
    Macedo, Joana C. Leon
    Gutierrez, Maria Fernanda
    Lopez, Zeudi C. Valera
    Daghero, Andrea
    DIABETES, 2022, 71
  • [42] MiniMed 780G™ advanced hybrid closed-loop system performance in Egyptian patients with type 1 diabetes across different age groups: evidence from real-world users
    Nancy Samir Elbarbary
    Eman Abdel Rahman Ismail
    Diabetology & Metabolic Syndrome, 15
  • [43] Real-world data on the Minimed 780G advanced hybrid closed-loop system use during type 1 diabetes pregnancy: One centre observational study
    Munda, Ana
    Kovacic, Chiara
    Barlovic, Drazenka Pongrac
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (08)
  • [44] Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical Evidence
    Choudhary, Pratik
    Arrieta, Arcelia
    van den Heuvel, Tim
    Castaneda, Javier
    Smaniotto, Vittorino
    Cohen, Ohad
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 : 32 - 37
  • [45] MiniMed 780G™ advanced hybrid closed-loop system performance in Egyptian patients with type 1 diabetes across different age groups: evidence from real-world users
    Elbarbary, Nancy Samir
    Ismail, Eman Abdel Rahman
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [46] MINIMED 780™G SIX-MONTH USE ON CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES: A REAL-WORLD STUDY
    Passanisi, S.
    Salzano, G.
    Bombaci, B.
    Bonfanti, R.
    Delvecchio, M.
    Di Candia, F.
    Maffeis, C.
    Mozzillo, E.
    Piccinno, E.
    Piona, C.
    Rigamonti, A.
    Scialabba, F.
    Lombardo, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A125 - A125
  • [47] MiniMed 780g system and children with type 1 diabetes followed for one year: lessons learned from diabetes educators
    Almajaly, D.
    Petroviski, G.
    Rangarajan, R.
    Campbell, J.
    Pasha, M.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 354 - 354
  • [48] Safety and Glycemic Outcomes Using the MiniMed 780G System with a Disposable All-in-One Sensor with Transmitter
    Forlenza, Gregory P.
    MacLeish, Sarah A.
    Shulman, Dorothy I.
    Nwosu, Benjamin U.
    Accacha, Siham
    Garg, Satish K.
    Carlson, Anders L.
    Castorino, Kristin N.
    Marks, Brynn E.
    Lal, Rayhan
    Pihoker, Catherine
    Thrasher, James
    Laffel, Lori M.
    Sunil, Bhuvana
    Bode, Bruce W.
    Sherr, Jennifer L.
    Ekhlaspour, Laya
    Reed, John H.
    Abuzzahab, M. Jennifer
    Church, Mei Mei
    Dai, Zheng
    Ma, Haoxi
    Solomon, Jed
    Treminio, Yuri
    Shin, John
    Rhinehart, Andrew S.
    McVean, Jennifer
    Vigersky, Robert A.
    DIABETES, 2024, 73
  • [49] MiniMed™ 780G Advanced Hybrid Closed-Loop System Study in Pregnant Women with Type 1 Diabetes
    Guibert, Clara
    Amoura, Lamia
    Rakotoarisoa, Luc
    Plat, Francoise
    Sonnet, Emmanuel
    Lablanche, Sandrine
    Treglia, Clemence
    Sarde, Elisa
    Leca, Viviane
    Rimareix, Frederique
    Melki, Vincent
    Baucher, Franciane
    Betari, Bouchra
    Meyer, Laurent
    Kessler, Laurence
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (12) : 893 - 901
  • [50] DURABLE HIGH GLUCOMETRIC PERFORMANCE OF THE MINIMED 780G ADVANCED HYBRID CLOSED LOOP SYSTEM IN REAL WORLD EVALUATION IN A VALUE BASED DIABETES CENTER (DIABETER NETHERLANDS)
    Mul, D.
    Arrieta, A.
    Aanstoot, H. J.
    Castaneda, J.
    Da Silva, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A94 - A95
12345